Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
14.45
-0.27 (-1.83%)
At close: Apr 3, 2025, 4:00 PM
14.43
-0.02 (-0.14%)
After-hours: Apr 3, 2025, 5:09 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.73 billion as of April 3, 2025. Its market cap has decreased by -18.13% in one year.
Market Cap
3.73B
Enterprise Value
12.15B
1-Year Change
-18.13%
Ranking
Category
Stock Price
$14.45
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.73B, a decrease of -55.71%. That is a compound annual growth rate of -18.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 3.80B | -1.18% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |